Skip to main content

Advertisement

SpringerLink
Log in

Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Osteoporosis is a disease associated with insulin resistant states such as central obesity, diabetes, and metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) is also increased in such conditions. However, little is known about whether osteoporosis and nonalcoholic fatty liver disease are etiologically related to each other or not. We examined whether bone mineral density (BMD) is associated with NAFLD in pre- and postmenopausal women. Four hundred eighty-one female subjects (216 premenopausal and 265 postmenopausal) were enrolled. Lumbar BMD was measured using dual-energy X-ray absorptiometry. Liver ultrasonography was done to check the severity of fatty liver. We excluded subjects with a secondary cause of liver disease. Blood pressure, lipid profile, fasting plasma glucose, alanine aminotransferase (ALT), aspartate aminotransferase, and body mass index were measured in every subject. Mean lumbar BMD was lower in subjects with NAFLD than those without NAFLD in postmenopausal women (0.98 ± 0.01 vs. 1.01 ± 0.02 g/cm2, P = 0.046). Multiple correlation analysis revealed a significant association between mean lumbar BMD and NAFLD in postmenopausal subjects after adjusting for age, body mass index, ALT, smoking status, and alcohol consumption (β coefficient −0.066, 95% CI −0.105 to −0.027, P = 0.001). Even after adjusting the presence of metabolic syndrome, the significance was maintained (β coefficient −0.043, 95% CI −0.082 to −0.004, P = 0.031). Lumbar BMD is related with NAFLD in postmenopausal females. We suggest that postmenopausal women with NAFLD may have a higher risk of osteoporosis than those without.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 94(6), 646–650 (1993)

    Google Scholar 

  2. C. Cooper, E.J. Atkinson, S.J. Jacobsen, W.M. O’Fallon, L.J. Melton 3rd, Population-based study of survival after osteoporotic fractures. Am. J. Epidemiol. 137(9), 1001–1005 (1993)

    PubMed  CAS  Google Scholar 

  3. M.A. Petit, M.L. Paudel, B.C. Taylor, J.M. Hughes, E.S. Strotmeyer, A.V. Schwartz, J.A. Cauley, J.M. Zmuda, A.R. Hoffman, K.E. Ensrud, Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J. Bone Miner. Res. 25(2), 285–291 (2010)

    Google Scholar 

  4. D. von Muhlen, S. Safii, S.K. Jassal, J. Svartberg, E. Barrett-Connor, Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos. Int. 18(10), 1337–1344 (2007)

    Article  Google Scholar 

  5. D.K. Hwang, H.J. Choi, The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos. Int. 21(3), 425–431 (2010)

    Google Scholar 

  6. Kim, K.C., Shin, D.H., Lee, S.Y., Im, J.A., Lee, D.C.: Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J 51(6), 857–863 (2010)

    Google Scholar 

  7. Y.K. Jeon, J.G. Lee, S.S. Kim, B.H. Kim, S.J. Kim, Y.K. Kim, I.J. Kim, Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr. J. 58(2), 87–93 (2011)

    Google Scholar 

  8. M.A. Cornier, D. Dabelea, T.L. Hernandez, R.C. Lindstrom, A.J. Steig, N.R. Stob, R.E. Van Pelt, H. Wang, R.H. Eckel, The metabolic syndrome. Endocr. Rev. 29(7), 777–822 (2008)

    Article  PubMed  CAS  Google Scholar 

  9. G.A. Bray, T. Bellanger, Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29(1), 109–117 (2006)

    Article  PubMed  CAS  Google Scholar 

  10. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106(25), 3143–3421 (2002)

    Google Scholar 

  11. A.I. Shulman, D.J. Mangelsdorf, Retinoid x receptor heterodimers in the metabolic syndrome. N. Engl. J. Med. 353(6), 604–615 (2005)

    Article  PubMed  CAS  Google Scholar 

  12. E. Scorletti, P.C. Calder, C.D. Byrne, Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. Endocrine 40(3), 332–343 (2011)

    Google Scholar 

  13. S.M. Grundy, Metabolic complications of obesity. Endocrine 13(2), 155–165 (2000)

    Article  PubMed  CAS  Google Scholar 

  14. G. Targher, L. Bertolini, R. Padovani, S. Rodella, R. Tessari, L. Zenari, C. Day, G. Arcaro, Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30(5), 1212–1218 (2007)

    Article  PubMed  Google Scholar 

  15. S. Bellentani, G. Saccoccio, F. Masutti, L.S. Croce, G. Brandi, F. Sasso, G. Cristanini, C. Tiribelli, Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med. 132(2), 112–117 (2000)

    PubMed  CAS  Google Scholar 

  16. J.R. Lewis, S.R. Mohanty, Nonalcoholic fatty liver disease: a review and update. Dig. Dis. Sci. 55(3), 560–578 (2010)

    Google Scholar 

  17. M. Lazo, J.M. Clark, The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 28(4), 339–350 (2008)

    Article  PubMed  Google Scholar 

  18. C. Loguercio, T. De Simone, M.V. D’Auria, I. de Sio, A. Federico, C. Tuccillo, A.M. Abbatecola, C. Del Vecchio Blanco, Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Dig. Liver Dis. 36(6), 398–405 (2004). doi:10.1016/j.dld.2004.01.022

  19. C. Loguercio, V. De Girolamo, I. de Sio, C. Tuccillo, A. Ascione, F. Baldi, G. Budillon, L. Cimino, A. Di Carlo, M.P. Di Marino, F. Morisco, F. Picciotto, L. Terracciano, R. Vecchione, V. Verde, C. Del Vecchio Blanco, Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J. Hepatol. 35(5), 568–574 (2001)

    Article  PubMed  CAS  Google Scholar 

  20. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communication, Sydney (2000)

  21. A.J. Sanyal, AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123(5), 1705–1725 (2002)

    Article  PubMed  Google Scholar 

  22. D. Joy, V.R. Thava, B.B. Scott, Diagnosis of fatty liver disease: Is biopsy necessary? Eur. J. Gastroenterol. Hepatol. 15(5), 539–543 (2003)

    PubMed  Google Scholar 

  23. S.H. Park, W.K. Jeon, S.H. Kim, H.J. Kim, D.I. Park, Y.K. Cho, I.K. Sung, C.I. Sohn, D.K. Keum, B.I. Kim, Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21(1 Pt 1), 138–143 (2006)

    Article  PubMed  Google Scholar 

  24. J.M. Clark, F.L. Brancati, A.M. Diehl, Nonalcoholic fatty liver disease. Gastroenterology 122(6), 1649–1657 (2002)

    Article  PubMed  Google Scholar 

  25. A. Suzuki, M.F. Abdelmalek, Nonalcoholic fatty liver disease in women. Womens Health (Lond. Engl.) 5(2), 191–203 (2009)

    Article  Google Scholar 

  26. Y.H. Hsu, S.A. Venners, H.A. Terwedow, Y. Feng, T. Niu, Z. Li, N. Laird, J.D. Brain, S.R. Cummings, M.L. Bouxsein, C.J. Rosen, X. Xu, Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am. J. Clin. Nutr. 83(1), 146–154 (2006)

    Google Scholar 

  27. L.J. Zhao, Y.J. Liu, P.Y. Liu, J. Hamilton, R.R. Recker, H.W. Deng, Relationship of obesity with osteoporosis. J. Clin. Endocrinol. Metab. 92(5), 1640–1646 (2007). doi:10.1210/jc.2006-0572

    Google Scholar 

  28. W.Y. Lee, J.S. Park, S.Y. Noh, E.J. Rhee, K.C. Sung, B.S. Kim, J.H. Kang, S.W. Kim, M.H. Lee, J.R. Park, C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int. J. Cardiol. 97(1), 101–106 (2004)

    Article  PubMed  Google Scholar 

  29. D.H. Jones, Y.Y. Kong, J.M. Penninger, Role of RANKL and RANK in bone loss and arthritis. Ann. Rheum. Dis. 61(Suppl 2), ii32–39 (2002)

    Google Scholar 

  30. L.C. Hofbauer, M. Schoppet, Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292(4), 490–495 (2004)

    Article  PubMed  CAS  Google Scholar 

  31. M. Krawczyk, L. Bonfrate, P. Portincasa, Nonalcoholic fatty liver disease. Best Pract. Res. Clin. Gastroenterol. 24(5), 695–708 (2010)

    Google Scholar 

  32. P. Trayhurn, I.S. Wood, Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem. Soc. Trans. 33(Pt 5), 1078–1081 (2005)

    PubMed  CAS  Google Scholar 

  33. P. Trayhurn, Adipose tissue in obesity—an inflammatory issue. Endocrinology 146(3), 1003–1005 (2005)

    Article  PubMed  CAS  Google Scholar 

  34. T. Diamond, D. Stiel, M. Lunzer, M. Wilkinson, J. Roche, S. Posen, Osteoporosis and skeletal fractures in chronic liver disease. Gut 31(1), 82–87 (1990)

    Article  PubMed  CAS  Google Scholar 

  35. P. Angulo, T.M. Therneau, A. Jorgensen, C.K. DeSotel, K.S. Egan, E.R. Dickson, J.E. Hay, K.D. Lindor, Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J. Hepatol. 29(5), 729–735 (1998)

    Article  PubMed  CAS  Google Scholar 

  36. S.P. Pereira, G.P. Bray, P.I. Pitt, F. Li, C. Moniz, R. Williams, Non-invasive assessment of bone density in primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 11(3), 323–328 (1999)

    Article  PubMed  CAS  Google Scholar 

  37. J. Newton, R. Francis, M. Prince, O. James, M. Bassendine, D. Rawlings, D. Jones, Osteoporosis in primary biliary cirrhosis revisited. Gut 49(2), 282–287 (2001)

    Article  PubMed  CAS  Google Scholar 

  38. G.W. McCaughan, R.B. Feller, Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management. Dig. Dis. 12(4), 223–231 (1994)

    Article  PubMed  CAS  Google Scholar 

  39. C.H. Janes, E.R. Dickson, R. Okazaki, S. Bonde, A.F. McDonagh, B.L. Riggs, Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95(6), 2581–2586 (1995)

    Article  PubMed  CAS  Google Scholar 

  40. F.J. Gallego-Rojo, J.L. Gonzalez-Calvin, M. Munoz-Torres, J.L. Mundi, R. Fernandez-Perez, D. Rodrigo-Moreno, Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 28(3), 695–699 (1998)

    Article  PubMed  CAS  Google Scholar 

  41. J.A. Cuthbert, C.Y. Pak, J.E. Zerwekh, K.D. Glass, B. Combes, Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4(1), 1–8 (1984)

    Article  PubMed  CAS  Google Scholar 

  42. G. Mazziotti, M. Gola, A. Bianchi, T. Porcelli, A. Giampietro, V. Cimino, M. Doga, C. Gazzaruso, L. De Marinis, A. Giustina, Influence of diabetes mellitus on vertebral fractures in men with acromegaly. Endocrine 40(1), 102–108 (2011)

    Google Scholar 

  43. G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41(1), 58–69 (2012)

    Google Scholar 

Download references

Acknowledgment

The authors appreciate the help of Professor Jong-Sup Kim of Kyungpook National University Hospital for collecting data.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Dongguk University School of Medicine, Dongdae-ro 87, Gyeongju, Gyeongbuk province, 780-350, South Korea

    Seong-Su Moon & Young-Sil Lee

  2. Department of Radiology, Dongguk University School of Medicine, Gyeongju, South Korea

    Sung Woo Kim

Authors
  1. Seong-Su Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Young-Sil Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sung Woo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seong-Su Moon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moon, SS., Lee, YS. & Kim, S.W. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 42, 423–429 (2012). https://doi.org/10.1007/s12020-012-9639-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9639-6

Keywords

Search

Navigation